ClinicalTrials.gg
RecruitingNCT06852248ICEUpdated Sep 3, 2025

Ureteric Identification Using Indocyanine Green Dye Versus Conventional Ureteric Stenting to Reduce Post-operative Pain and Surgical Morbidity During Endometriosis Surgery

An observational study in Endometriosis and Deep Endometriosis, sponsored by University Hospitals of North Midlands NHS Trust. Recruiting at 1 site in United Kingdom. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-09-03.

Sponsored by University Hospitals of North Midlands NHS Trust · Observational

How we know

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
70
Ages
18 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Endometriosis with a site in United Kingdom — 10 open to participants now, 11 under way, none of them phase 3. Endometriosis · United Kingdom.

Planned enrollment
9th of 12
70 · median 100
Started
2025
with 5 others
Observational
12 of 25
8 open now
Primary completion
2027-03
later than 4 of 10 live
Registered
18th of 25
by date

Among the 25 studies in Endometriosis with a site in United Kingdom, this one is the 9th largest by planned enrollment of the 12 observational ones that give a count, is one of 6 that started in 2025, is one of 12 observational ones, reaches primary completion later than 4 of the 10 other live ones, and was the 18th registered.

Endometriosis

924 studies on the registry are indexed under Endometriosis; 268 are open to participants now.

Browse Endometriosis studies →

Open to participants now

10 of the 25 studies in Endometriosis with a site in United Kingdom are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 180 Endometriosis studies recruiting now, 53 (29%) set no upper age limit and 125 (69%) stop at 75 or younger; 18 take children under 18; 39 take healthy volunteers.

This study: 18 Years to 50 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Endometriosis with a site in United Kingdom, or all of them as a file.
02

Study summary

Endometriosis is a common (around 1 in 10 women), non-cancerous condition where tissue similar to the womb lining is found growing elsewhere, most commonly inside the pelvis. Symptoms vary but can include intense pelvic pain and infertility.

Endometriosis that is very deep and painful may need surgery, which risks damage to the tubes that drain urine from the kidneys to the bladder (ureters). To reduce this risk, surgeons may put tiny plastic tubes called "stents" inside the ureters. These stents can stay for up-to 4 weeks following surgery but can cause severe pain and blood in the urine. Squirting a dye into the ureters, rather than using stents, may cause less pain for women after surgery whilst not making the removal of endometriosis worse, the operation take longer, or increasing the rates of complications (such as bleeding or damage to internal organs). Before a full clinical study can be run, the investigators need to understand whether this is possible, by doing a feasibility study

03

Conditions studied

  • Endometriosis
  • Deep Endometriosis

Browse trials for

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women with deep endometriosis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 18 to 50 years
  • Scheduled for laparoscopic or robotic-assisted surgical excision of deep endometriosis (DE) where ureteric stenting is planned.
  • Willing and able to provide consent for participation in the study

Exclusion criteria

Exclusion Criteria:

  • Confirmed or suspected pregnancy at the time of enrolment.
  • Suspicion or confirmation of .
  • History of ureteric injury from prior surgery or trauma
  • Medically unfit for surgery due to the following conditions:

    • Uncontrolled diabetes mellitus.
    • Severe (COPD).
    • Hypertrophic cardiomyopathy or significant cardiac conditions (e.g., recent myocardial infarction, aortic stenosis).
    • History of stroke or severe kyphoscoliosis.
    • Uncontrolled hypertension.
  • (BMI): BMI greater than 45
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • Ureteric stenting

    One group will have conventional ureteric stenting (temporary tubes placed in the ureters).

    Procedure: Ureteric stenting

  • Indocyanine green (ICG) dye

    One group will receive indocyanine green (ICG) dye injected into the ureters to make them visible under a special light.

    Procedure: Indocyanine green (ICG) dye

Interventions

  • ProcedureUreteric stenting

    The ICE trial is a pilot study involving two methods for identifying the ureters (tubes connecting the kidneys to the bladder) during endometriosis surgery. One group will have conventional ureteric stenting (temporary tubes placed in the ureters)

  • ProcedureIndocyanine green (ICG) dye

    The ICE trial is a pilot study involving two methods for identifying the ureters (tubes connecting the kidneys to the bladder) during endometriosis surgery. One group will receive indocyanine green (ICG) dye injected into the ureters to make them visible under a special light.

06

What researchers measure

Primary outcomes

  1. Number of eligible women

    The number of eligible women across 2 UK sites that are suitable for trial recruitment

    Time frame: 24 months

  2. Proportion of eligible women agreeing to participate

    Number of women who are eligible that then take part in the trial

    Time frame: 24 months

  3. Attrition rate in follow up process

    Recording the percentage of people who drop out before the completion

    Time frame: 24 months

  4. Missing data in follow up process

    Recording how much data is missing from the follow up data

    Time frame: 24 months

  5. Acceptability of the trial interventions and follow-up processes

    Recording how acceptable surgeons find the trial interventions and follow up process.

    Time frame: 24 months

  6. Acceptability of the trial interventions and follow-up processes

    Recording how acceptable participants find the trial interventions and follow up process. This will be done using a focus group

    Time frame: 24 months

  7. Reasons for declining participation or withdrawal after agreeing to participate

    Recording the list of reasons people withdraw from the study or decline to take part

    Time frame: 24 months

07

Study locations

1 of 1 sites recruiting
  • University Hospitals of North Midlands NHS Trust
    Stoke-on-Trent, Staffordshire ST4 6QG, United Kingdom
    Recruiting
    • Aviva Ogbolosingha · Contact
    • Gourab Misra · Principal investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Mar 2027, 20 months after the start.

Of 158 non-industry observational studies under Endometriosis, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 48. This study's planned 20 months is below that.

Counting every sponsor, half of 185 studies reached it within 30 months; a quarter within 14 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 18, 2025
First posted
Feb 28, 2025
StartActual
Jul 29, 2025
Primary completionEst.
Mar 2027
CompletionEst.
Mar 2028
Last update
Sep 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06852248
Lead sponsor
University Hospitals of North Midlands NHS Trust
Responsible party
Sponsor
First posted
Feb 28, 2025
Start date
Jul 29, 2025
Primary completion
Mar 2027 (estimated)
Completion
Mar 2028 (estimated)
Last update
Sep 3, 2025

Study contacts

Aviva Ogbolosingha
Contact
aviva.ogbolosingha@uhnm.nhs.uk
01782675380

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion